热门资讯> 正文
Apogee Therapeutics公开募股定价3亿美元
2025-10-09 14:18
- Apogee Therapeutics (NASDAQ:APGE) priced its public offering at $41 per share, raising ~$300M in gross proceeds.
- The offering includes 6.95M common shares and 365,853 pre-funded warrants priced at $41 each.
- Pre-funded warrants are exercisable immediately.
- Offering is expected to close on October 10, 2025.
- Apogee granted underwriters a 30-day option to purchase up to 1.1M additional shares.
- Proceeds will support the company’s clinical-stage biologics pipeline targeting inflammatory and immunology markets.
- Source: Press release
More on Apogee Therapeutics
- Apogee Therapeutics announces underwritten public offering
- Seeking Alpha’s Quant Rating on Apogee Therapeutics
- Historical earnings data for Apogee Therapeutics
- Financial information for Apogee Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
